Screener
Castle Biosciences CSTL Business Segments — Professional services
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept cstl:ProfessionalServices.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Significant segment expenses: | ||
| Personnel costs | 58,367 | 52,200 |
| Organizational and marketing costs | 15,594 | 14,229 |
| Inventory usage | 6,437 | 4,731 |
| Clinical studies and publication costs | 2,542 | 2,085 |
| Professional services | 3,007 | 3,576 |
| Other segment items | 12,254 | 37,015 |
| Segment loss | $(14,522) | $(25,848) |
Item 1. Financial Statements.
FAQ
- What is Castle Biosciences's business segments — professional services?
- Castle Biosciences (CSTL) reported business segments — professional services of $3.01M in Q1 2026.
- How has Castle Biosciences's business segments — professional services changed year-over-year?
- Castle Biosciences's business segments — professional services decreased by 15.9% year-over-year, from $3.58M to $3.01M.
- What is the long-term trend for Castle Biosciences's business segments — professional services?
- Over 3 years (2022 to 2025), Castle Biosciences's business segments — professional services has grown at a 2.8% compound annual growth rate (CAGR), from $10.07M to $10.93M.
- What does business segments — professional services mean?
- Covers fees paid to third-party consultants, legal experts, and specialized service providers supporting the segment's operations. It highlights the reliance on external expertise to manage specialized business functions.
Ask your AI about Castle Biosciences's business segments — professional services.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude